Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety

BACKGROUND AND OBJECTIVE: Oral levodopa-carbidopa (LC-oral) treatment in advanced Parkinson’s disease (PD) is associated with motor complications due to large fluctuations in levodopa plasma concentrations. Levodopa–carbidopa intestinal gel (LCIG) provides individualized continuous levodopa–carbidop...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Ahmed A., Chatamra, Krai, Mohamed, Mohamed-Eslam F., Dutta, Sandeep, Benesh, Janet, Yanagawa, Masayoshi, Nagai, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559582/
https://www.ncbi.nlm.nih.gov/pubmed/25875940
http://dx.doi.org/10.1007/s40262-015-0265-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559582/
https://www.ncbi.nlm.nih.gov/pubmed/25875940
http://dx.doi.org/10.1007/s40262-015-0265-3

Ejemplares similares